News

Is the FDA Doing Enough About Food Additives?
Food dyes are known to have a wide range of impacts on health, such as cancer risks, behavioral problems in children, and ...
People living with Alzheimer's ‒ and their caregivers ‒ need more than hope | Opinion
My husband has Alzheimer's, and my experience as his caregiver influenced me to make 'Walk With Me,' a documentary that ...
FDA Head Marty Makary on Food Dyes, Ultra-Processed Foods and the MAHA Agenda
The Food and Drug Administration commissioner reveals what health officials are prioritizing in a forthcoming report on ...
100 days into the job, FDA head talks to CNN about agency goals— and Coke’s switch to sugar
Commissioner Marty Makary says the FDA will plow ahead with big plans on ultra process foods, dietary guidelines and ...
EU regulator green lights an injectable HIV drug that could help stop transmission
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...
The difference between palliative care and hospice
Many tend to confuse palliative care, which is focused on symptom management, with hospice care, which requires that all ...
Lawmakers press FDA to target knockoff weight-loss drug
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...
FDA names former pharmaceutical company executive to oversee US drug program
FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...
Biotech exec George Tidmarsh picked as FDA's chief drug regulator
The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...
FDA appoints biotech veteran George Tidmarsh to lead drug evaluation division
Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...
FDA appoints George Tidmarsh as top drug regulator
The U.S. Food and Drug Administration said on Monday it has appointed George Tidmarsh, a seasoned biotech executive and ...
US FDA extends review of GSK's blood cancer drug
The U.S. Food and Drug Administration has extended its review of GSK's blood cancer drug, Blenrep, as a combination treatment ...